Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge Setup Score
Trend Edge rates ANIX Bearish with a Setup Score of 7, net conviction 25, actionability 2. How the Setup Score works →
Total Setup Score
7
Directional Bias
Bearish
Net Conviction
25
Actionability
2 (in range)
Key signals behind this score
40wk Downtrend — trend only (sma 3.16 vs px 3.25)
Fresh Breakdown — 200wk turn 12w+40wk turn 21w
200wk Downtrend — falling+below (sma 3.41 vs px 3.25)
Funds Distributing — momZ +1.42 · 0.79→0.72
RS Breakdown — momZ +0.25 · low 9w×1.00 · vs industry
About Anixa Biosciences Inc
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: January 1, 1987
Headquarters: 3150 Almaden Expressway, San Jose, CA, United States, 95118
Founder-Led: Yes — Amit Kumar (CEO, Chairman & Co-Chair of CBAB)
Key Metrics
Current Price
$3.25
Market Cap
$117M
Float
32.2M
Shares Outstanding
34.0M
Price/Sales (TTM)
377.78
vs. Analyst Target
+207.7% to analyst PT
Dividend Rate
None
Analyst Target Price
$10.00 (3 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
N/A
-$10.1M
-$90,157
-$10.0M
2021
$512,000
-$12.9M
$127,000
-$13.1M
2022
$2.47B
-$13.6M
$2.47B
-$13.7M
2023
$210,000
-$9.8M
$49,000
-$9.9M
2024
N/A
-$12.6M
-$37,000
-$12.7M
2025
N/A
-$10.9M
-$36,000
-$11.0M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jul 2025
N/A
-$2.3M
Oct 2025
N/A
-$2.7M
Jan 2026
N/A
-$2.6M
Apr 2026
N/A
-$2.6M
Ownership & Float
Insider Ownership
5.5%
Institutional Ownership
13.4%
Short Float
2.7%
% of All Funds Holding
0.72%
Number of Funds Holding
59
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$3.17
Near-term / short-term trend
Weekly
40-Week SMA
$3.16
Medium-term trend
Weekly
80-Week SMA
$3.15
Cyclical trend (business cycle)
Weekly
200-Week SMA
$3.41
Secular trend (multi-year)
Monthly
10-Month SMA
$3.15
Near-term monthly trend
Monthly
20-Month SMA
$3.13
Medium-term monthly trend
Monthly
40-Month SMA
$3.19
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$2.80
support
1.37x
0 months ago
$4.50
resistance
3.13x
7 months ago
$2.40
support
1.22x
18 months ago
$2.20
support
1.21x
24 months ago
Historical Earnings Reactions (108 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.55%
0.00%
39.81%
30.54%
-14.29%
1 Day
0.14%
0.00%
34.26%
22.22%
-12.50%
1 Week
5.60%
1.17%
50.93%
93.94%
-23.15%
2 Weeks
10.91%
-0.47%
43.52%
483.33%
-31.25%
1 Month
7.82%
-2.02%
42.06%
377.27%
-38.71%
Next earnings: September 9, 2026 (28 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
10.2%
55.8%
43
Feb
-1.9%
30.2%
43
Mar
0.6%
34.9%
43
Apr
2.5%
44.2%
43
May
3.2%
44.2%
43
Jun
-2.3%
30.2%
43
Jul
0.1%
32.6%
43
Aug
5.4%
52.4%
42
Sep
11.0%
47.6%
42
Oct
-1.4%
40.5%
42
Nov
4.9%
48.8%
43
Dec
-4.2%
37.2%
43
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-0.13%
36.2%
2038
Tuesday
-0.11%
38.0%
2214
Wednesday
0.27%
40.9%
2211
Thursday
0.15%
39.8%
2170
Friday
0.70%
42.5%
2158
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 13.4%
Insider Transactions — Smart Summary
Total insider ownership: 5.5%
Founder-led management: Amit Kumar (CEO, Chairman & Co-Chair of CBAB)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Anixa Biosciences Inc
(ANIX) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.